Radioimmunotherapy of solid tumors targeting a cell-surface protein, FZD10: therapeutic efficacy largely depends on radiosensitivity-Reference-Cited by-同舟云学术

Radioimmunotherapy of solid tumors targeting a cell-surface protein, FZD10: therapeutic efficacy largely depends on radiosensitivity

Published:2009-05-02 Issue:5 Volume:23 Page:479-485
ISSN:0914-7187
Container-title:Annals of Nuclear Medicine
language:en
Short-container-title:Ann Nucl Med

Author:

Hanaoka Hirofumi,Katagiri Toyomasa,Fukukawa Chikako,Yoshioka Hiroki,Yamamoto Shinji,Iida Yasuhiko,Higuchi Tetsuya,Oriuchi Noboru,Paudyal Bishnuhari,Paudyal Pramila,Nakamura Yusuke,Endo Keigo

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12149-009-0265-1.pdf

Reference28 articles.

1. Witzig TE, Molina A, Gordon LI, Emmanouilides C, Schilder RJ, Flinn IW, et al. Long-term responses in patients with recurring or refractory B-cell non-Hodgkin lymphoma treated with yttrium 90 ibritumomab tiuxetan. Cancer 2007;109:1804–10.

2. Fisher RI, Kaminski MS, Wahl RL, Knox SJ, Zelenetz AD, Vose JM, et al. Tositumomab and iodine-131 tositumomab produces durable complete remissions in a subset of heavily pretreated patients with low-grade and transformed non-Hodgkin’s lymphomas. J Clin Oncol. 2005;23:7565–73.

3. Verhaar-Langereis MJ, Zonnenberg BA, de Klerk JM, Blijham GH. Radioimmunodiagnosis and therapy. Cancer Treat Rev. 2000;26:3–10.

4. Goldenberg DM. Advancing role of radiolabeled antibodies in the therapy of cancer. Cancer Immunol Immunother. 2003;52:281–96.

5. Jhanwar YS, Divgi C. Current status of therapy of solid tumors. J Nucl Med. 2005;46:141S–50S.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FZD10‐targeted α‐radioimmunotherapy with 225 Ac‐labeled OTSA101 achieves complete remission in a synovial sarcoma model;Cancer Science;2021-12-21

2. WNT/β-Catenin Pathway in Soft Tissue Sarcomas: New Therapeutic Opportunities?;Cancers;2021-11-03

3. Antibody Conjugates for Sarcoma Therapy: How Far along Are We?;Biomedicines;2021-08-08

4. Targeting fatty acid synthase sensitizes human nasopharyngeal carcinoma cells to radiation via downregulating frizzled class receptor 10;Cancer Biology and Medicine;2020

5. Less Exploited GPCRs in Precision Medicine: Targets for Molecular Imaging and Theranostics;Molecules;2018-12-23